USTEKINUMAB-AEKN

USTEKINUMAB-AEKN was reported 6 times

USTEKINUMAB-AEKN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CEREBRAL VENOUS SINUS THROMBOSIS 1 0.0012
1 JUGULAR VEIN THROMBOSIS 1 0.0006
2 TUNNEL VISION 1 0.0005
3 FEAR OF INJECTION 1 0.0001
4 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 1 0.0001
5 FOLLICULITIS 1 0.0001
6 WOUND INFECTION 1 0.0001
7 OCULAR DISCOMFORT 1 0.0001
8 BURSITIS 1 0.0001
9 HAND DEFORMITY 1 0.0001
10 DRUG EFFECT LESS THAN EXPECTED 1 0.0001
11 BRAIN FOG 1 0.0001
12 SYNOVITIS 1 0.0001
13 PHOTOPHOBIA 1 0.0001
14 TASTE DISORDER 1 0.0000
15 GLOSSODYNIA 1 0.0000
16 WOUND 1 0.0000
17 DRUG-INDUCED LIVER INJURY 1 0.0000
18 TYPE 2 DIABETES MELLITUS 1 0.0000
19 SYSTEMIC LUPUS ERYTHEMATOSUS 1 0.0000
20 C-REACTIVE PROTEIN INCREASED 1 0.0000
21 THERAPEUTIC PRODUCT EFFECT DECREASED 1 0.0000
22 BLOOD CHOLESTEROL INCREASED 1 0.0000
23 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 1 0.0000
24 INFLAMMATION 1 0.0000
25 ARTHROPATHY 1 0.0000
26 WHEEZING 1 0.0000
27 ILL-DEFINED DISORDER 1 0.0000
28 HEPATIC ENZYME INCREASED 1 0.0000
29 INJECTION SITE REACTION 1 0.0000
30 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1 0.0000
31 MOBILITY DECREASED 1 0.0000
32 GASTROOESOPHAGEAL REFLUX DISEASE 1 0.0000
33 TREATMENT FAILURE 1 0.0000
34 MATERNAL EXPOSURE DURING PREGNANCY 1 0.0000
35 GASTROINTESTINAL DISORDER 1 0.0000
36 DRUG INTOLERANCE 1 0.0000
37 GENERAL PHYSICAL HEALTH DETERIORATION 1 0.0000
38 JOINT SWELLING 1 0.0000
39 HYPOAESTHESIA 1 0.0000
40 CONFUSIONAL STATE 1 0.0000
41 URTICARIA 1 0.0000
42 ABDOMINAL DISCOMFORT 1 0.0000
43 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1 0.0000
44 ALOPECIA 1 0.0000
45 ABDOMINAL PAIN UPPER 1 0.0000
46 HYPERTENSION 1 0.0000
47 WEIGHT INCREASED 1 0.0000
48 DECREASED APPETITE 1 0.0000
49 VOMITING 2 0.0000
50 ASTHENIA 1 0.0000
51 ARTHRALGIA 1 0.0000
52 DIZZINESS 1 0.0000
53 DYSPNOEA 1 0.0000
54 HEADACHE 1 0.0000
55 FATIGUE 1 0.0000
56 OFF LABEL USE 1 0.0000